Cargando…
Emerging drug design strategies in anti-influenza drug discovery
Influenza is an acute respiratory infection caused by influenza viruses (IFV), According to the World Health Organization (WHO), seasonal IFV epidemics result in approximately 3–5 million cases of severe illness, leading to about half a million deaths worldwide, along with severe economic losses and...
Autores principales: | Liu, Chuanfeng, Hu, Lide, Dong, Guanyu, Zhang, Ying, Ferreira da Silva-Júnior, Edeildo, Liu, Xinyong, Menéndez-Arias, Luis, Zhan, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692392/ https://www.ncbi.nlm.nih.gov/pubmed/38045039 http://dx.doi.org/10.1016/j.apsb.2023.08.010 |
Ejemplares similares
-
Current trends in designing antiviral agents against emerging and re-emerging RNA viruses
por: da Silva-Júnior, Edeildo F., et al.
Publicado: (2022) -
Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
por: Xu, Shujing, et al.
Publicado: (2022) -
Recent Advances in Application of Computer-Aided Drug Design in Anti-Influenza A Virus Drug Discovery
por: Yu, Dahai, et al.
Publicado: (2022) -
Druggable targets from coronaviruses for designing new antiviral drugs
por: Silva, Leandro Rocha, et al.
Publicado: (2020) -
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
por: Jia, Ruifang, et al.
Publicado: (2022)